MedPath

Effect of both PRP and 15% AHA versus 15% AHA alone on facial wrinkles

Phase 3
Conditions
Facial wrinkles.
Registration Number
IRCT20140705018373N5
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Age between 18 to 45 years
Satisfaction to participate in the study

Exclusion Criteria

Platelet disorder or blood clots
Chronic liver disease
Autoimmune diseases
History of drug treatment with bleeding or clotting mechanisms,
Having cosmetic treatments in the past 6 months
Pregnancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Facial wrinkles severity. Timepoint: Initiation of the study, 1, 3 and 6 months after the intervention. Method of measurement: Wrinkle Severity Rating Scale.;Degree of tissue healing and homogeneity of facial skin. Timepoint: Initiation of the study, 1, 3 and 6 months after the intervention. Method of measurement: Skin Homogeneity and Texture Scale.;Patient satisfaction. Timepoint: 6 months after the intervention. Method of measurement: Asking from patients on a scale of 1 to 5 range from very dissatisfied to very satisfied.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath